DOCSLIB.ORG

Neutralizing Antibody to Herpes Simplex Virus Type 1 in Patients with Oral Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neutralizing Antibody to Herpes Simplex Virus Type 1 in Patients with Oral Cancer , .. Neutralizing Antibody to Herpes Simplex Virus Type 1 in Patients with Oral Cancer EDWARD J. SHILLITOE, BDS, PHD, DEBORAH GREENSPAN, BDS, JOHN'S. GREENSPAN, BDS, PHD, MRCPATH, LOUIS S. HANSEN, DDS, MS, AND SOL SILVERMAN JR, MA, DDS Neutralizing antibody to Herpes simplex virus type 1 (HSV-1), type 2, and measles virus was IQeasured in the serum of patients with oral cancer, patients with oral leukoplakia, and in control subjects who were smokers and nonsmokers. Significantly higher titers to HSV-1 were found in contrQJs who smoked than in controls who did not smoke. Patients with untreated oral cancer had HSV-1 neutralizing titers siQI~Iar to those of the controls who smqked, but those with later stage tumors bad higher titers tha!l those with earlier stage tumors. In patients who were tumor free after treatment for oral cancer, higher antibody titers to HSV-1 were associated with longer survival times. No association was found between clinical status and antibody to measles virus. The data are consistent with a role for both HSV-1 and smoking in the pathogenesis of orid cancer. Cancer 49:2315-2320, 1982. RAGMENTARY EVIDENCE has accumulated to sug­ neutralizing antib9dies in oral cancer patients, in pa­ F gest a connection between the H~rpes simplex vi­ tients with leukoplakia who are therefore at risk of de­ rus type 1 (HSV-1) and cancer of the mouth. 1 Lehner veloping oral cancer,9 in smokers, who also have an et al. 2 found an increased cell-medi~ted immune re­ incre&sed risk pf oral cancer, 10 and in control subjects sponse to HSV-1 in patients having oral leukoplakia who do not smoke. For comparison we also measured with epithelial atypia as compared with patients having antibody to measles virus, which has not been associated oral leukoplakia without atypia, or control subjects. with any human cancer. The results were comp~red Ma~ignant change was accompanied by a specific fall with the clinical and histologic status of each patient, in the response. 3 Oral cancer patients may have cir­ and a prospective study has been started. culating antibody to tumor-associated antigens derived 4 5 from HSV-1, • but the tumor specificity of such anti­ Materials and Methods gens is in doubt because independent efforts to confirm 6 7 8 Patients their specificity have failed, • • sera from patients with acute or recurrent herpetic infections have not been The 102 patients in this study were drawn from pa­ tested, and other viruses have not been used as controls. tients attending the Oral Medjcine clinic at the Uni­ In fact, it is not well established whether patients with versity of California, San Francisco. This clinic is part oral cancer have higher or lower antibody responses to of a regional center for the treatment of head and neck HSV when standard laboratory tests, such as virus neu­ cancer that serves all of Northern California. All pa­ tralization, are applied. tients with head and neck cancer who attend the med­ This communication describes HSV-1 and HSV-2 ical center are examined in this clinic before treatment is begun, and are recalled at least twice a year after From the Department of Oral Medicine and Hospital Dentistry, treatme~t is concluded. About 50 patients with un­ School of Dentistry, University of California, San Francisco, Cali- treated oral squamous cell carcinoma are seen per ye~r. fornia. · Supported by the Cancer Research Coordinating Committee of the Consecutive patients were entered into this study for University of California, by grant RR05305-18 from the Biomedical up to one year, until enough had been included: 1\bout Research Support Grant Program, and by NIH grant 1 ROl one-third of the patients in the series were excluded DE05330-0l. because of a history of malignant disease at another Edward J. Shillitoc is ~ecipient of Research Career Development Award No. 1 K04 DE 00088-01. site, treatment with immunosuppressive drugs for any Address for reprints: Edward J. Shillitoc, BDS, PhD, S-653, Uni­ reason, or a history of recurrent herpetic infection; the versity of California, San Francisco CA 94143. The authors thank Belma A. Enriquez for technical assistance. patients were otherwise unselected. Subjects were di­ Accepted for publication March 23, 1981. vided into these five groups: 0008-543X/82/0601/2315 $0.80@ American Cancer Society 2315 .. 2316 CANCER June 1 1982 • Vol. 49 512 (1) Oral cancer, untreated. Twenty-one patients had untreated primary squamo~s cell carcinoma of the tongue, palate, floor of mouth, or gingiva. 256 ..... .. ... ..... -- Their ages ranged from 34-76, with a mean of 59.5 years. There were 14 q~.en and seven women, 128 ~ ... •• -·· ... •• and 20 (95%) were cigarette smokers. The stag€l of each tumor was a~sessed according to the method of the Americ;an Joint for li4 ... ........ Com~ittee + 11 1/HS¥~1 Cancer Staging and Epd Results reporting. Tltor (2) Oral cancer, treated. Nineteen patients had be~n 32 t • • t f - treated in the past for oral squamous cell car- - cinoma at sites-comparable to those of the un- 16 treated patients, and had remained tumor-free since treatment was completed. Treatment had + consisted of surgery, radiatiop therapy, or both. These patients were in good health at the time • of testing and were ranged ip age from 26-72, Dr1l C1ncer Dr1l C1ncer Loukopllktl Non·SIIIIIktng Smaktng Untr ..tod Trutod Controls Controls with a mean of 59.6. Twelve were men and seven Z51i were women. Sixteen (84%) had been cigarette smokers when the tumor was diagnosed, at w~ich time six had then quit. 128 .. • •• (3) Leukoplakia. The WHO definition of leuko- plakia was adopted-namely, a white plaque of 64 • • •• the oral mucos!l that cannpt be characterized 9 1/HSV-2 -- - clinically or histologically as any other disease. Titer A group of 21 patients with this condition was 32 .. -·· ·- - -· studied; their ages ranged from 36-84 years with a mean of 63 years. Niqe were men and 12 were 16 !'"- women. Eight were cigarette smokers, one was l -· -· =F a pipe smoker, and four had quit smoking several + years previously. At the time of diagnosis, there- • t ..... - + fore, 62% were smokers. (4) Dr1l Concer Oral C1ncer Leukopli~i• llan-...,king Smoking Controls whopid not smoke. A group of 21 non- Untrutod Tl'!lited Controls Controls smokers were assembled from patients attending the same clinic as the cancer patients. None had ever'"'been smokers. They were ultimately diag- i I nosed as having nonmalignant conditions unre- 204 .. - -- .. - lated to virus infections, such as aphthous ulcers, ( lichen pla,nus, or mucous membrane pemphigoid. 1024 ... .. .. • Ages ranged from 30-94, with a mean of 54.8 \ - ·-· years; nine were men and 12 were women. I I (5) Controls who ·were smokers. A group of 20 cig- 512 .... I -:1: I 1/Heaslos arette smokers was assembled in the same way Titer f ·+ T as were the nonsmokers. Ages ranged from 28- 256 - •• - •• 66, with a mean of 45.4 years. There were 12 :r men and eight women. ~ 128 • ••• The majority of patients in each group were social ·-· - - drinkers. One patient with untreated oral cancer was l an alc;oholic, but there were no other differences in 64 ••• drinking habits among the various groups. Serum was l <64 .. i Ural Concer Dr1l Concer Leukophkh Non-sa~~ktng Sllaking obtained from each patient and was stored at -20 C ' Untreated . Treoted Control,. Controls I before testing. I FIG. 1. Neutralization titers to HSV-1 (top), HSV-2 (center), and measles virus (bottom) of serum from patients with untreated oral Virus Neutralization Tests can~;er, treated oral cancer, and leukoplakia; controls who were non- smokers; and control subjects who smoked. Bars represent the geo- HSV-1 (14-012 strain), HSV-2 (333 strain), and l metric mean titer of each group ± 1 standard error of the mean. measles virus (Edmunston strain) were obtained from No. II HERPES ANTIBODIES IN ORAL CANCER • Shil/itoe et al. 2317 Dr. F. Rapp (Hershey, PA). Each virus was propagated 256 .... ••• in Vero cells until the cytopathic effect involved 80% of the monolayer. The cells were scraped into the me­ 12 dium and disrupted by ultrasonic vibration, and debris • was pelleted by centrifugation at 1000g for 15 min­ utes. The supernatant was stored in 0.5 ml volumes at 64 ••• + -70 c. 1/HSV-1 Serum from each patient was inactivated at 56 C for Tfter 1 hour and serially diluted in Hank's Balanced Salt 32 •• Solution,_starting at a dilution of 1:8. Equal volumes 3 t of diluted serum and virus at i X 10 plaque-forming unitsfml were mixed and allowed to stand at room tem­ 16 perature for 1 hour. The mixture was plated in 0.2-ml volumes onto monolayers of Vero cells in 60..:mm Petri • dishes and left to adsorb for 1 hour. The dish was then <8 overlaid_with Hank's Balanced Sait Solution containing 1-11 'III-IV 2% fetal calf serum, 0.5% methylcellulose, and 2.25 gf Tumor staye liter of sodium bicarbonate, and incubated for four days at 37 C. The cells were then fixed, stained with crystal 256 • violet, and plaques were counted. The antibody neu­ tralization titer was taken to be the highest serum di­ lution that reduced plaques by over 50%, compared with 128 •• plaques in dishes with mediu~ in place of the patients' serum. The ratio of HSV-2 antibodies to HSV-1 anti­ 64 •• • bodies (the II/I ratio) was caiculated by the method 1/HSV-2 of Rawls et al.
Load more

Recommended publications
  • The Treatment of Herpes Labialis with a Diode Laser (970 Nm) — a Field Study
    I clinical article The treatment of herpes labialis with a diode laser (970 nm)—a field study DrSimoneSuppelt AbstrAct Herpes labialis is an infection caused by the herpes simplex virus HSV 1 and, less frequently, HSV 2. In dental prac - tices the diode laser is mainly used in periodontology, endodontics and minimally invasive surgery. Many of those affected by herpes are unaware that laser treatment can successfully alleviate their symptoms. In this field study, 11 patients who suffer from acute herpes were treated with a 970 nm diode laser. The areas which the patients described as being affected by herpes were irradiated at a distance of 1 –3 mm (2.0 W, 10 Hz, 50 % duty cycle, 320 µm optical fiber). Several patients felt the symptoms subside during the treatment. For the majority of patients, the symptoms did not occur again after treatment. All of the patients were satisfied with the treatment. Laser treatment of herpes labialis using a 970 nm diode laser is an effective way for me to help my patients both quickly and simply. Keywords Diode laser, 970 nm, herpes labialis, HSV Introduction An outbreak of herpes labialis can be accompanied by var - ious symptoms. As a rule, in the early stages such symptoms With a wavelength of 970 nm and a maximum output of include dry lips and a tingling/itching sensation. In subsequent 7W cw, the SIROLaser Advance dental diode laser has a wide stages, swelling and a feeling of tightness occur which can range of indications. In my practice, the laser is mainly used rapidly be accompanied by a sensation of burning or other in periodontology and endodontics to reduce germs in pock - sense of pain.
    [Show full text]
  • Oral Manifestations of Systemic Disease Their Clinical Practice
    ARTICLE Oral manifestations of systemic disease ©corbac40/iStock/Getty Plus Images S. R. Porter,1 V. Mercadente2 and S. Fedele3 provide a succinct review of oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease. While the majority of disorders of the mouth are centred upon the focus of therapy; and/or 3) the dominant cause of a lessening of the direct action of plaque, the oral tissues can be subject to change affected person’s quality of life. The oral features that an oral healthcare or damage as a consequence of disease that predominantly affects provider may witness will often be dependent upon the nature of other body systems. Such oral manifestations of systemic disease their clinical practice. For example, specialists of paediatric dentistry can be highly variable in both frequency and presentation. As and orthodontics are likely to encounter the oral features of patients lifespan increases and medical care becomes ever more complex with congenital disease while those specialties allied to disease of and effective it is likely that the numbers of individuals with adulthood may see manifestations of infectious, immunologically- oral manifestations of systemic disease will continue to rise. mediated or malignant disease. The present article aims to provide This article provides a succinct review of oral manifestations a succinct review of the oral manifestations of systemic disease of of systemic disease. It focuses upon oral mucosal and salivary patients likely to attend oral medicine services. The review will focus gland disorders that may arise as a consequence of systemic upon disorders affecting the oral mucosa and salivary glands – as disease.
    [Show full text]
  • Herpes: a Patient's Guide
    Herpes: A Patient’s Guide Herpes: A Patient’s Guide Introduction Herpes is a very common infection that is passed through HSV-1 and HSV-2: what’s in a name? ....................................................................3 skin-to-skin contact. Canadian studies have estimated that up to 89% of Canadians have been exposed to herpes simplex Herpes symptoms .........................................................................................................4 type 1 (HSV-1), which usually shows up as cold sores on the Herpes transmission: how do you get herpes? ................................................6 mouth. In a British Columbia study, about 15% of people tested positive for herpes simplex type 2 (HSV-2), which Herpes testing: when is it useful? ..........................................................................8 is the type of herpes most commonly thought of as genital herpes. Recently, HSV-1 has been showing up more and Herpes treatment: managing your symptoms ...................................................10 more on the genitals. Some people can have both types of What does herpes mean to you: receiving a new diagnosis ......................12 herpes. Most people have such minor symptoms that they don’t even know they have herpes. What does herpes mean to you: accepting your diagnosis ........................14 While herpes is very common, it also carries a lot of stigma. What does herpes mean to you: dating with herpes ....................................16 This stigma can lead to anxiety, fear and misinformation
    [Show full text]
  • Hairy Leukoplakia James E
    Marquette University e-Publications@Marquette School of Dentistry Faculty Research and Dentistry, School of Publications 5-5-2017 Hairy Leukoplakia James E. Cade Meharry Medical College School of Dentistry Richard P. Vinson Paul L Foster School of Medicine Jeff urB gess University of Washington School of Dental Medicine Sanjiv S. Agarwala Temple University Shool of Medicine Denis P. Lynch Marquette University, [email protected] See next page for additional authors Published version. Medscape Drugs & Diseases (May 5, 2017). Publisher link. © 2017 by WebMD LLC. Used with permission. Authors James E. Cade, Richard P. Vinson, Jeff urB gess, Sanjiv S. Agarwala, Denis P. Lynch, and Gary L. Stafford This blog post/website is available at e-Publications@Marquette: https://epublications.marquette.edu/dentistry_fac/252 Overview Background Oral hairy leukoplakia (OHL) is a disease of the mucosa first described in 1984. This pathology is associated with Epstein-Barr virus (EBV) and occurs mostly in people with HIV infection, both immunocompromised and immunocompetent, and can affect patients who are HIV negative.{ref1}{ref2} The first case in an HIV-negative patient was reported in 1999 in a 56-year-old patient with acute lymphocytic leukemia. Later, many cases were reported in heart, kidney, and bone marrow transplant recipients and patients with hematological malignancies.{ref3}{ref4} Pathophysiology The Epstein-Barr virus (EBV), a ubiquitous herpesvirus estimated to infect 90% of the world's population, is linked to a growing number of diseases, especially in immunocompromised hosts. Like all herpesviruses, EBV establishes a life-long, persistent infection of its host. The pathogenesis of hairy leukoplakia is clearly complex, potentially requiring a convergence of factors including EBV co-infection, productive EBV replication, EBV genetic evolution, expression of specific EBV "latent" genes, and immune escape.
    [Show full text]
  • VALTREX (Valacyclovir Hydrochloride) Caplets Hypersensitivity to Valacyclovir (E.G., Anaphylaxis), Acyclovir, Or Any Initial U.S
    Valacyclovir oral suspension (25 mg/mL or 50 mg/mL) can be prepared from HIGHLIGHTS OF PRESCRIBING INFORMATION the 500 mg VALTREX Caplets. (2.3) These highlights do not include all the information needed to use VALTREX safely and effectively. See full prescribing information for --------------------- DOSAGE FORMS AND STRENGTHS -------------- VALTREX. Caplets: 500 mg (unscored), 1 gram (partially scored) (3) -------------------------------CONTRAINDICATIONS------------------------ ® VALTREX (valacyclovir hydrochloride) Caplets Hypersensitivity to valacyclovir (e.g., anaphylaxis), acyclovir, or any Initial U.S. Approval: 1995 component of the formulation. (4) ---------------------------RECENT MAJOR CHANGES -------------------- ----------------------- WARNINGS AND PRECAUTIONS ---------------- Indications and Usage, Pediatric Patients (1.2) 9/2008 • Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome Dosage and Administration, Pediatric Patients (2.2, 2.3) 9/2008 (TTP/HUS): Has occurred in patients with advanced HIV disease and in ----------------------------INDICATIONS AND USAGE--------------------- allogenic bone marrow transplant and renal transplant patients receiving VALTREX is a nucleoside analogue DNA polymerase inhibitor indicated for: 8 grams per day of VALTREX in clinical trials. Discontinue treatment if Adult Patients (1.1) clinical symptoms and laboratory findings consistent with TTP/HUS • Cold Sores (Herpes Labialis) occur. (5.1) • Genital Herpes • Acute renal failure: May occur in elderly patients (with or without •
    [Show full text]
  • Symptoms and Signs of Herpes Simplex Virus What to Do—HERPES! Provider’S Guide for Uncommon Suspected Sexual Abuse Scenarios Ann S
    Symptoms and Signs of Herpes Simplex Virus What to Do—HERPES! Provider’s Guide for Uncommon Suspected Sexual Abuse Scenarios Ann S. Botash, MD Background Herpes can present in any of several ways: • herpetic gingivostomatitis • herpetic whitlow, • herpes labialis • herpes gladiotorum • genital herpes • herpes encephalitis • herpetic keratoconjuctivitis • eczema herpeticum The differential diagnosis of ulcerative lesions in the genital area is broad. Infectious causes: • chancroid • syphilis, • genital HSV infection • scabies, • granuloma inguinale (donovanosis) • CMV or EBV • candida, • varicella or herpes zoster virus (VZV) • lymphogranuloma venereum Non-infectious causes: • lichen planus • Behçet syndrome • trauma History Symptoms Skin lesions are typically preceded by prodromal symptoms: • burning and paresthesia at the •malaise site •myalgia • lymphadenopathy •loss of appetite • fever •headaches Exposure history Identify anyone with any of the various presentations of genital or extra- genital ulcers. Determine if there has been a recurrence. Determine if there are any risk factors for infection: • eczematous skin conditions • immunocompromised state of patient and/or alleged perpetrator. Rule out autoinoculation or consensual transmission. Physical Cutaneous lesions consist of small, monomorphous vesicles on an erythematous base that rupture into painful, shallow, gray erosions or ulcerations with or without crusting. Clinical diagnosis of genital herpes is not very sensitive or specific. Obtain laboratory cultures for a definitive diagnosis. Lab Tests Viral culture (gold standard)—preferred test • Must be from active lesions. • Vigorously swab unroofed lesion and inoculate into a prepared cell culture. Antigen detection • Order typing of genital lesions in children. • DFA distinguishes between HSV1 & 2, EIA does not. Cytologic detection • Tzanck Prep is insensitive (50%) and non-specific. • PCR testing is sensitive and specific but the role in the diagnosis of genital ulcers is unclear.
    [Show full text]
  • Spectrum of Lip Lesions in a Tertiary Care Hospital: an Epidemiological Study of 3009 Indian Patients
    Brief Report Spectrum of Lip Lesions in a Tertiary Care Hospital: An Epidemiological Study of 3009 Indian Patients Abstract Shivani Bansal, Aim: Large‑scale population‑based screening studies have identified lip lesions to be the most Sana Shaikh, common oral mucosal lesions; however, few studies have been carried out to estimate the prevalence Rajiv S. Desai, of lip lesions exclusively. The aim of present study is to highlight the diversity of lip lesions and determine their prevalence in an unbiased Indian population. Materials and Methods: Lip lesions Islam Ahmad, were selected from 3009 patients who visited the department over a period of 3 years (January Pavan Puri, 2012 to December 2014). Age, sex, location of lip lesions, a detailed family and medical history, Pooja Prasad, along with the history of any associated habit was recorded. Biopsy was carried out in necessary Pankaj Shirsat, cases to reach a final diagnosis. The pathologies of the lip were classified based on the etiology. Dipali Gundre Results: Among 3009 patients, 495 (16.5%) had lip lesions ranging from 4 years to 85 years with a Department of Oral Pathology, mean age of 39.7 years. There were 309 (62.4%) males and 185 (31.9%) females. Lower lip was the Nair Hospital Dental College, most affected region (54.1%) followed by the corner of the mouth (30.9%) and upper lip (11.7%). Mumbai Central, Mumbai, In 3.2% of the cases, both the lips were involved. Of the 495 lip lesions, the most common were Maharashtra, India Potentially Malignant Disorders (PMDs) (37.4%), herpes labialis (33.7%), mucocele (6.7%), angular cheilitis (6.1%), and allergic and immunologic lesions (5.7%).
    [Show full text]
  • Severe Herpes Simplex Virus Type-I Infections After Dental Procedures
    Med Oral Patol Oral Cir Bucal. 2011 Jan 1;16 (1):e15-8. Extraction-related herpes Journal section: Oral Medicine and Pathology doi:10.4317/medoral.16.e15 Publication Types: Case Report http://dx.doi.org/doi:10.4317/medoral.16.e15 Severe herpes simplex virus type-I infections after dental procedures Lara El Hayderi, Laurent Raty, Valerie Failla, Marie Caucanas, Dilshad Paurobally, Arjen F. Nikkels Department of Dermatology, University Medical Center Liège, Belgium Correspondence: Department of Dermatology University Medical Center of Liège El Hayderi L, Raty L, Failla V, Caucanas M, Paurobally D, Nikkels AF. B-4000 Liège, Belgium. Severe herpes simplex virus type-I infections after dental procedures. [email protected] Med Oral Patol Oral Cir Bucal. 2011 Jan 1;16 (1):e15-8. http://www.medicinaoral.com/medoralfree01/v16i1/medoralv16i1p15.pdf Received: 05-01-2010 Article Number: 16956 http://www.medicinaoral.com/ Accepted: 30-03-2010 © Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946 eMail: [email protected] Indexed in: Science Citation Index Expanded Journal Citation Reports Index Medicus, MEDLINE, PubMed Scopus, Embase and Emcare Indice Médico Español Abstract Background: Recurrences of herpes labialis (RHL) may be triggered by systemic factors, including stress, men- ses, and fever. Local stimuli, such as lip injury or sunlight exposure are also associated to RHL. Dental extraction has also been reported as triggering event. Case reports: Seven otherwise healthy patients are presented with severe and extensive RHL occurring about 2-3 days after dental extraction under local anaesthesia. Immunohistochemistry on smears and immunofluorescence on cell culture identified herpes simplex virus type I (HSV-I).
    [Show full text]
  • Comparative Evaluation of the Efficacy of Systemic Levamisole And
    Journal of Advanced Clinical & Research Insights (2019), 6, 33–38 ORIGINAL ARTICLE Comparative evaluation of the efficacy of systemic levamisole and antioxidant in the management of oral submucous fibrosis – A randomized control trial Anuja Anil Shinge1, Preeti Kanchan-Talreja1, Deepa Das1, Amita Navalkar1, Prakash S. Talreja2, Ashutosh Kakade3 1Department of Oral Medicine and Radiology, Y.M.T. Dental College and Hospital, Navi Mumbai, Maharashtra, India, 2Department of Periodontics, Bharati Vidyapeeth Dental College and Hospital, Navi Mumbai, Maharashtra, India, 3Department of Pharmacology, M.G.M Medical College and Hospital, Navi Mumbai, Maharashtra, India Keywords: Abstract Cap. Antoxid, tab. levamisole, oral submucous Background: Oral submucous fibrosis (OSF) is a chronic, disabling disease involving fibrosis the entire oral mucosa, mainly reported in Indian population. A number of treatment Correspondence: modalities have been tried, but none of these have been completely therapeutic. Dr. Anuja Anil Shinge, Department of Levamisole, an immunomodulator, has been reported to be beneficial in oral mucosal Oral Medicine and Radiology, Y.M.T. lesions, but there are hardly any studies reported in literature for OSF patients, and Dental College and Hospital, Dr. G. D. Pol hence, the study was taken up. Foundations, Kharghar, Institutional Area, Aim: This study aims to compare the efficacy of levamisole with antioxidant for the Navi Mumbai - 410210. assessment of burning sensation and mouth opening in OSF patients. E-mail: [email protected] Materials and Methods: A total of 60 patients clinically diagnosed of OSF were selected for the study. We assessed patients for burning sensation and mouth opening. Patients Received: 02 February 2019; were divided into four groups according to staging of OSF (More et al., classification), Accepted: 11 March 2019 then randomly subdivided into three groups to dispense medicines.
    [Show full text]
  • 1. Oral Infections.Pdf
    ORAL INFECTIONS Viral infections Herpes Human Papilloma Viruses Coxsackie Paramyxoviruses Retroviruses: HIV Bacterial Infections Dental caries Periodontal disease Pharyngitis and tonsillitis Scarlet fever Tuberculosis - Mycobacterium Syphilis -Treponema pallidum Actinomycosis – Actinomyces Gonorrhea – Neisseria gonorrheae Osteomyelitis - Staphylococcus Fungal infections (Mycoses) Candida albicans Histoplasma capsulatum Coccidioides Blastomyces dermatitidis Aspergillus Zygomyces CDE (Oral Pathology and Oral Medicine) 1 ORAL INFECTIONS VIRAL INFECTIONS • Viruses consist of: • Single or double strand DNA or RNA • Protein coat (capsid) • Often with an Envelope. • Obligate intracellular parasites – enters host cell in order to replicate. • 3 most commonly encountered virus families in the oral cavity: • Herpes virus • Papovavirus (HPV) • Coxsackie virus (an Enterovirus). DNA Viruses: A. HUMAN HERPES VIRUS (HHV) GROUP: 1. HERPES SIMPLEX VIRUS • Double stranded DNA virus. • 2 types: HSV-1 and HSV-2. • Lytic to human epithelial cells and latent in neural tissue. Clinical features: • May penetrate intact mucous membrane, but requires breaks in skin. • Infects peripheral nerve, migrates to regional ganglion. • Primary infection, latency and recurrence occur. • 99% of cases are sub-clinical in childhood. • Primary herpes: Acute herpetic gingivostomatitis. • 1% of cases; severe symptoms. • Children 1 - 3 years; may occur in adults. • Incubation period 3 – 8 days. • Numerous small vesicles in various sites in mouth; vesicles rupture to form multiple small shallow punctate ulcers with red halo. • Child is ill with fever, general malaise, myalgia, headache, regional lymphadenopathy, excessive salivation, halitosis. • Self limiting; heals in 2 weeks. • Immunocompromised patients may develop a prolonged form. • Secondary herpes: Recurrent oral herpes simplex. • Presents as: a) herpes labialis (cold sores) or b) recurrent intra-oral herpes – palate or gingiva.
    [Show full text]
  • World Journal of Clinical Cases
    World Journal of W J C C Clinical Cases Submit a Manuscript: http://www.wjgnet.com/esps/ World J Clin Cases 2014 December 16; 2(12): 866-872 Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx ISSN 2307-8960 (online) DOI: 10.12998/wjcc.v2.i12.866 © 2014 Baishideng Publishing Group Inc. All rights reserved. MINIREVIEWS Precancerous lesions of oral mucosa Gurkan Yardimci, Zekayi Kutlubay, Burhan Engin, Yalcin Tuzun Gurkan Yardimci, Department of Dermatology, Muş State Hos- alternatives such as corticosteroids, calcineurin inhibi- pital, 49100 Muş, Turkey tors, and retinoids are widely used. Zekayi Kutlubay, Burhan Engin, Yalcin Tuzun, Department of Dermatology, Cerrahpaşa Medical Faculty, Istanbul University, © 2014 Baishideng Publishing Group Inc. All rights reserved. 34098 Istanbul, Turkey Author contributions: Kutlubay Z designed research; Yardımci Key words: Oral premalignant lesions; Leukoplakia; G performed research; Tuzun Y contributed new reagents or ana- Erythroplakia; Submucous fibrosis; Lichen planus; Ma- lytic tools; Engin B analyzed data; Yardımci G wrote the paper. Correspondence to: Zekayi Kutlubay, MD, Department of lignant transformation Dermatology, Cerrahpaşa Medical Faculty, Istanbul University, Cerrah Paşa Mh., 34098 Istanbul, Core tip: Precancerous lesions of oral mucosa are the Turkey. [email protected] diseases that have malignant transformation risk at dif- Telephone: +90-212-4143120 Fax: +90-212-4147156 ferent ratios. Clinically, these diseases may sometimes Received: July 22, 2014 Revised: August 28, 2014 resemble each other. Thus, the diagnosis should be Accepted: September 23, 2014 confirmed by biopsy. In early stages, histopathological Published online: December 16, 2014 findings are distinctive, but if malignant transformation occurs, identical histological features with oral carci- noma are seen.
    [Show full text]
  • Oral Diseases Associated with Human Herpes Viruses: Aetiology, Clinical Features, Diagnosis and Management
    www.sada.co.za / SADJ Vol 71 No. 6 CLINICAL REVIEW < 253 Oral diseases associated with human herpes viruses: aetiology, clinical features, diagnosis and management SADJ July 2016, Vol 71 no 6 p253 - p259 R Ballyram1, NH Wood2, RAG Khammissa3, J Lemmer4, L Feller5 ABSTRACT Human herpesviruses (HHVs) are very prevalent DNA ACRONYMS viruses that can cause a variety of orofacial diseases. EM: erythema multiforme Typically they are highly infectious, are contracted early in HHV: human herpes virus life, and following primary infection, usually persist in a latent form. Primary oral infections are often subclinical, but may PCR: polymerase chain reaction be symptomatic as in the case of herpes simplex virus- HSV, HHV-1: herpes simplex virus induced primary herpetic gingivostomatitis. Reactivation VZV, HHV-3: varicella-zoster virus of the latent forms may result in various conditions: herpes EBV, HHV-4: Epstein-Barr virus simplex virus (HSV) can cause recurrent herpetic orolabial CMV, HHV-5: cytomegalovirus lesions; varicella zoster virus (VZV) can cause herpes zoster; Epstein-Barr virus (EBV) can cause oral hairy Key words: herpes simplex virus, human herpes virus-8, leukoplakia; and reactivation of HHV-8 can cause Kaposi varicella zoster virus, Epstein-Barr virus, recurrent herpes sarcoma. In immunocompromised subjects, infections labialis, recurrent intraoral herpetic ulcers, treatment, val- with human herpesviruses are more extensive and aciclovir, aciclovir, famcicylovir. severe than in immunocompetent subjects. HSV and VZV infections are treated with nucleoside analogues aciclovir, valaciclovir, famciclovir and penciclovir. These agents INTRODucTION have few side effects and are effective when started The human herpesvirus (HHV) family comprises a diverse early in the course of the disease.
    [Show full text]